Vortioxetine and the one-year experience in Malaysia
17 Mar 2017
4.2 million Malaysians above the age of 16 suffer from poor mental health and related issues
On 6 November 2016, in conjunction with the first year anniversary of vortioxetine (Brintellix®, Lundbeck) in Malaysia, two distinguished speakers, Professor Gin S Malhi and Dr Pranab Kalita shared updates on depression and the use of vortioxetine in order to help patients with major depressive disorders (MDD) to return to their premorbid functional states. The session was followed by three case presentations.
Related MIMS Drugs